Beta
Liothyronine
medicationSynthetic T3 thyroid hormone (brand name: Cytomel). Sometimes used with or instead of T4 for hypothyroidism. Shorter half-life than levothyroxine.
Reported Benefits
Treatment of Hypothyroidism That Contains Liothyronine is Associated with Reduced Dementia and Mortality Risk
Not specified in search results
A large retrospective cohort study analyzing 1.26 million hypothyroid patients comparing levothyroxine monotherapy, levothyroxine plus liothyronine combination therapy, and desiccated thyroid extract. Propensity score matching analysis indicated 27% and 31% lower dementia and mortality risks respectively with combination therapy compared to levothyroxine alone, though the adjusted Cox model showed more modest reductions of 16% and 25%.
Treatment of Hypothyroidism That Contains Liothyronine is Associated with Reduced Dementia and Mortality Risk
Not specified in search results
A large retrospective cohort study analyzing 1.26 million hypothyroid patients comparing levothyroxine monotherapy, levothyroxine plus liothyronine combination therapy, and desiccated thyroid extract. Propensity score matching analysis indicated 27% and 31% lower dementia and mortality risks respectively with combination therapy compared to levothyroxine alone, though the adjusted Cox model showed more modest reductions of 16% and 25%.
Treatment of Hypothyroidism That Contains Liothyronine is Associated with Reduced Dementia and Mortality Risk
Not specified in search results
A large retrospective cohort study analyzing 1.26 million hypothyroid patients comparing levothyroxine monotherapy, levothyroxine plus liothyronine combination therapy, and desiccated thyroid extract. Propensity score matching analysis indicated 27% and 31% lower dementia and mortality risks respectively with combination therapy compared to levothyroxine alone, though the adjusted Cox model showed more modest reductions of 16% and 25%.
No side effects tracked yet
No side effects have been reported by studies or users for this habit yet.
Related health conditions
Research showing how this habit affects specific health conditions. Always consult healthcare professionals.
May Help With
Autoimmune disorder affecting thyroid function
Phase 1 Clinical Trial of Poly-Zinc-Liothyronine Demonstrates Slow Release
Not specified in search results
A Phase 1 double-blind, randomized, and controlled study in 12 healthy adult volunteers examining a novel poly-zinc-liothyronine formulation designed to provide slow, sustained release of liothyronine.
Research (2 studies)
Community updates
No updates yet for this supplement.
Be the first to share your experience!